Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

Image Credit: Dusan Petkovic - stock.adobe.com
Drinking Water Contaminants Linked to Higher Chronic Kidney Disease Risk

July 11th 2025

Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic kidney disease.

Medical personnel filing a syringe needle | Image Credit: MargJohnsonVA - stock.adobe.com.jpeg
SGLT2 Inhibitor Offers Kidney Protection and Reduces Heart Failure Risk After Acute Myocardial Infarction

July 10th 2025

FDA Approved. | Image Credit: Nirusmee - stock.adobe.com .jpeg
Oxylanthanum Carbonate Fails to Secure FDA Approval for Hyperphosphatemia, CKD

June 30th 2025

Woman laying on bed with mobile phone, using medical app | Prostock-studio - stock.adobe.com
Smartphone-Powered CKD Screening Yields 2.5-Fold Increase in Testing, Early Diagnoses

June 27th 2025

Clinical trial researchers interact with data | Image Credit: elenabsl - stock.adobe.com .jpeg
Lorundrostat Yields Promising Results for Treatment of Hypertension in Patients with CKD and Albuminuria

June 20th 2025

More News

Combination Therapy and Payer Perspective on CKD Therapies
September 28th 2022

Combination Therapy and Payer Perspective on CKD Therapies

Dr Bertram Pitt explains the possibility of combining SGLT2 inhibitors and MRAs when treating CKD and CV, and Paul Sapia, MHA, discusses how payers balance cost of care with disease progression and health disparities.
Using Published Data to Consider SGLT2 Inhibitors and MRAs in CKD Management
September 28th 2022

Using Published Data to Consider SGLT2 Inhibitors and MRAs in CKD Management

Dr Jeffrey Feldman discusses finerenone trial data and the role that it and SGLT2 inhibitors have played in patients with CKD.
Two people working at a computer
September 26th 2022

Kidney Transplant Recipients Able to Find Stable Work Post Surgery

Julia Bonavitacola
A recent report found that 56% of patients from The Netherlands who underwent a kidney transplant were able to work and functioned well while working.
Kidneys
September 24th 2022

Genomic Testing Could Be More Beneficial for Patients With CKD

Julia Bonavitacola
Genomic testing can benefit patients with chronic kidney disease (CKD) as more causative genes are identified and evidence for clinical utility is discovered.
The Role of MRAs in CKD and CV Treatment
September 21st 2022

The Role of MRAs in CKD and CV Treatment

Dr Agarwal provides a deep dive into the use of nonsteroidal mineralocorticoid receptor antagonists in CKD therapy.
Treating CKD Using Multiple Methods
September 21st 2022

Treating CKD Using Multiple Methods

Dr Feldman concludes the treatment landscape overview by discussing glycemic control, SGLT2 inhibitors, and other important management techniques.
Kidneys and heart
September 19th 2022

Use of Anticoagulants Has Increased for Patients With Atrial Fibrillation, CKD

Julia Bonavitacola
A recent study found that patients with chronic kidney disease and atrial fibrillation are increasingly using direct oral anticoagulants.
Air pollution
September 13th 2022

Improved Air Pollution Levels Linked With Less Renal Function Decline During COVID-19 Pandemic

Julia Bonavitacola
A retrospective cohort study found that a drop in events signaling renal function decline during the COVID-19 pandemic could be associated with a decrease in fine particulate matter concentration.
Milken Institute's Sarah Wells Kocsis Talks About CKD Care Moving Forward
September 8th 2022

Milken Institute's Sarah Wells Kocsis Talks About CKD Care Moving Forward

Julia Bonavitacola
Sarah Wells Kocsis, MBA, coauthor of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management,” discusses how the health care system can better suit the needs of patients with chronic kidney disease (CKD).
Weight scale
September 6th 2022

Low Handgrip Strength, Obesity Associated With Increased Risk of CKD in Women

Julia Bonavitacola
Post-menopausal women who had dynapenic-abdominal obesity, determined by hand-grip strength and waist circumference, had a higher risk of chronic kidney disease (CKD) compared with controls.
Sarah Wells Kocsis
August 30th 2022

Milken Institute's Sarah Wells Kocsis Outlines How to Improve Earlier Detection of CKD

Julia Bonavitacola
Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Milken Institute's Sarah Wells Kocsis on How Climate Change, Aging Impact CKD Care
August 24th 2022

Milken Institute's Sarah Wells Kocsis on How Climate Change, Aging Impact CKD Care

Julia Bonavitacola
Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
SGLT2 Inhibitors, Combination Therapy Needed to Stem the Tide of CKD in Diabetes
August 20th 2022

SGLT2 Inhibitors, Combination Therapy Needed to Stem the Tide of CKD in Diabetes

Mary Caffrey
Katherine R. Tuttle, MD, FASN, FACP, FNKF, a nephrologist from the University of Washington and Providence Health Care, discussed new consensus guidelines that call for the early use of sodium glucose cotransporter 2 (SGLT2) inhibitors, GLP-1 receptor agonists, and finerenone in the care of patients with both chronic kidney disease (CKD) and diabetes.
Sarah Wells Koscis, MBA, Milken Institute
August 14th 2022

Milken Institute's Sarah Wells Kocsis Highlights Key Findings of Her Research on CKD

Julia Bonavitacola
Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Money wrapped by a stethoscope
August 11th 2022

Largest Medicare Advantage Plans Pay Large Markups for Dialysis, Could Increase Out-of-Pocket Spending

Julia Bonavitacola
A recent study found that the largest Medicare Advantage plans pay large markups to large dialysis organizations, and these inflated payments could increase out-of-pocket expenses for patients.
As Health Disparities “Weave Their Way Through Hypertension,” New Agents Are on the Way
August 8th 2022

As Health Disparities “Weave Their Way Through Hypertension,” New Agents Are on the Way

Mary Caffrey
Coverage from the 2022 Congress of the American Society for Preventive Cardiology (ASPC) in Louisville, Kentucky, featuring 3 experts on aspects of hypertension treatment: Keith C. Ferdinand, MD, of Tulane University School of Medicine; Kim Allan Williams, MD, of the University of Louisville; and George C. Bakris, MD, of the University of Chicago Medicine.
Patient receiving care over Facetime
August 4th 2022

Remote Management of Renal Function May Reduce Mortality, HF Hospitalizations

Julia Bonavitacola
A new trial has found that patient management through remote means could reduce all-cause mortality and hospitalizations for heart failure (HF) in patients with renal impairment.
Surgeon holding kidney
August 1st 2022

Model Suggests Giving Kidneys to Patients on Dialysis a Better Use of Resources

Julia Bonavitacola
A recent modeling study found that allocating kidneys to patients receiving dialysis was a better use of the organs from a societal perspective compared with giving kidneys to those on a preemptive waiting list.
Older person's hands
July 30th 2022

Frailty Associated With Risk of ESKD, Mortality in Patients With CKD

Julia Bonavitacola
A retrospective cohort study found that frailty was prevalent in patients with chronic kidney disease (CKD) and that the adverse effects could include end stage kidney disease (ESKD) and mortality.
Kidneys
July 27th 2022

Lipid Dysregulation Predictive of CKD Risk, Onset

Julia Bonavitacola
A recent study found that lipid dysregulation was predictive of the risk of chronic kidney disease (CKD) and occurred years before the onset of CKD.
Factory pollution
July 21st 2022

Long-term Exposure to Air Pollution Associated With CKD

Julia Bonavitacola
A population-based cohort study found that carbon monoxide and sulfur dioxide exposure was associated with chronic kidney disease (CKD).
Kidneys and heart
July 18th 2022

Difference in eGFR Values Based on Cystatin C vs Creatinine Could Indicate Higher HF Risk

Julia Bonavitacola
A prospective cohort study found that in patients with chronic kidney disease, large differences in their glomerular filtration rate (eGFR) based on cystatin C vs creatinine were associated with risk of incident heart failure (HF).
Kidneys
July 15th 2022

Bidirectional Association Found Between Glaucoma, CKD

Julia Bonavitacola
A systematic review found that there was a bidirectional relationship between glaucoma and chronic kidney disease (CKD), especially in participants of East Asian descent.
Kidneys
July 12th 2022

Diet Therapy Can Improve Renal Function in Patients With CKD

Julia Bonavitacola
A randomized, controlled, nonblinded trial found that nutritional treatment with supportive education could help improve renal function in patients with chronic kidney disease (CKD).
Kidneys
July 3rd 2022

Top 2% of Genome-Wide Polygenic Score Indicates 3 Times the Risk of CKD

Julia Bonavitacola
A new genome-wide polygenic score was able to determine the risk of chronic kidney disease (CKD) in patients with a score in the top 2%.
Kidney disease.
June 29th 2022

Value-Based Frameworks Can Help Transform Kidney Care Delivery

Matthew Gavidia
The utility of value-based frameworks for payers, providers, and those involved in kidney care delivery was addressed during a session at AHIP 2022.
Kidneys
June 25th 2022

Patients With CKD Avoid Thinking About Disease, According to Study

Julia Bonavitacola
A qualitative study found that patients with chronic kidney disease (CKD) were more likely to avoid thinking about their disease because of the stress from dialysis.
What We're Reading
June 22nd 2022

What We’re Reading: FDA to Cut Nicotine Levels; Insulin Pricing Bill; DaVita Loses Dialysis Case

AJMC Staff
The FDA plans to set a maximum nicotine level in cigarettes and tobacco products to reduce addictiveness; a bipartisan bill would place a $35 monthly cap on insulin for patients with private insurance or Medicare; the Supreme Court ruled that an Ohio hospital’s employee health plan did not violate federal law by limiting coverage for outpatient dialysis.
Kidneys
June 21st 2022

ESA Usage Associated With Malignancy in Patients With CKD

Julia Bonavitacola
An observational study found that erythropoiesis-stimulating agent (ESA) usage was associated with increased risk of malignancies in patients with chronic kidney disease (CKD) or end-stage renal disease.
Kidneys
June 14th 2022

Study Finds Sodium-Glucose Cotransporter 2 Inhibitors Associated With Reduced Risk of CKD

Julia Bonavitacola
A retrospective cohort study found that sodium-glucose cotransporter 2 inhibitors were associated with a reduced risk of chronic kidney disease (CKD) in adults with type 2 diabetes.
<12345678
...
13>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo